Clinical study of intensity-modulated radiation therapy combined with chemotherapy in advanced cervical cancer

Objective To explore the clinical efficacy of intensity-modulated radiotherapy combined with chemotherapy in the treatment of advanced cervical cancer. Methods All 121 patients with advanced cervical cancer (stage ⅡB & ⅢA & ⅢB) selected in our hospital from June 2012 to June 2014, who were treated with combined chemoradiotherapy, were divided into observation group [intensity modulated radiation therapy (IMRT)group)] and control group [3-dimensional conformal radiation therapy (3D-CRT) group]. There was no significant difference between two groups in mean age, body mass index, International Federation of Gynecology and Obstetrics (FIGO) clinical stage, pathological type and chemotherapy mode (P>0.05). The clinical features of two groups were compared. The treatment and follow-up of two groups were recorded. Results The bone marrow suppression [32.2%(19/59) vs 51.6%(32/62)], gastrointestinal reaction [42.4%(25/59) vs 62.9%(39/62)], and rectal reaction rate [27.1%(16/59) vs 45.2%(28/62)] of the observation group were significantly less than that of the control group (P 0.05). Two groups were followed up for 3 years, the local control rate of the observation group was significantly higher than that of the control group (86.3% vs 70.1%) (P<0.05). Conclusions IMRT combined with chemotherapy in the treatment of advanced cervical cancer can improve the local control rate of tumor, protect the endangered organ, and reduce the side effects of radiotherapy. Key words: Uterine cervical neoplasms/DT/RT; Cisplatin/AD; Radiotherapy, intensity-modulated; Combined modality therapy